The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
CSL Behring Sp. z o.o.
+ business areaBioPharma R&D+Services
+ annual revenue
2020 - 211,500,000 PLN
2021 - 193,800,000 PLN
2022 - 164,500,000 PLN
2023 - 225,400,000 PLN
2024 - 250,500,000 PLN
+ depreciation & amortization
2020 - 171,700 PLN
2021 - 181,600 PLN
2022 - 292,400 PLN
2023 - 322,100 PLN
2024 - 246,800 PLN
CSL Behring Polska is part of the global CSL Behring group, focused on innovative therapies for rare and serious diseases such as blood clotting disorders, immune deficiencies, chronic inflammatory demyelinating polyneuropathy, hereditary angioedema, and alpha-1 antitrypsin deficiency. They provide recombinant and plasma-derived medicines.